WPI 3635 (Levetiracetam extended release 500 mg)

Pill imprint WPI 3635 has been identified as Levetiracetam extended release 500 mg.

Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; new daily persistent headache; hyperekplexia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WPI 3635 (Levetiracetam extended release 500 mg)

Levetiracetam extended release 500 mg WPI 3635
Levetiracetam extended release
Imprint:
WPI 3635
Strength:
500 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Pyrrolidine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)